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Oxygen producing microscale spheres aﬀect
cell survival in conditions of oxygen-glucose
deprivation in a cell speciﬁc manner: implications
for cell transplantation†
Heike Newland,a Dimitri Eigel,a Anne E. Rosser,b Carsten Werner a and
Ben Newland *a,c
This study outlines the synthesis of microscale oxygen producing
spheres, which, when used in conjunction with catalase, can raise
the dissolved oxygen content of cell culture media for
16–20 hours. In conditions of oxygen and glucose deprivation,
designed to mimic the graft environment in vivo, the spheres
rescue SH-SY5Y cells and meschymal stem cells, showing that
oxygen producing biomaterials may hold potential to improve the
survival of cells post-transplantation.
Cell death post transplantation is probably a multifactorial
issue, however, analysis of grafts immediately post transplan-
tation to the brain revealed that extreme hypoxic conditions
within the graft (especially the core) coincided with apoptosis
and death of the graft.1,2 This data may indicate that a lack of
oxygen in the graft may partially be to blame for the rapid cell
loss post transplantation.
One strategy for improving cerebral transplant survival may
therefore be to promote angiogenesis at the graft site, which
should improve the flow of oxygen and nutrients to the grafted
cells. In line with this strategy, researchers have developed
pharmacologically active microcarriers which release vascular
endothelial growth factor (VEGF) to the grafted cells in order
to increase angiogenesis at the graft site.3 Another strategy,
would be to provide oxygen to the grafted cells for the early
period post transplantation until vascularization of the graft
has occurred.4
Limited nutrient supply to the graft core is likely to aﬀect
diﬀerent cell types in diﬀerent ways. We synthesized oxygen
producing microspheres and analyzed the eﬀect these had on
the viability of three cell types cultured in conditions designed
to mimic deprivation of vital nutrients (oxygen and glucose).
The synthesis of biomaterials that produce or release oxygen is
a research field that has received much interest.5 Materials
that carry and release oxygen, such as fluorinated oils and
hemoglobin based oxygen carriers, have long been studied,
especially in the context of blood substitues.6 Biomaterials
that produce oxygen require an oxygen source such as sodium
percarbonate,7 calcium peroxide8–11 or sodium peroxide.12
Upon contact with water, and/or catalase, these oxygen sources
break down to yield molecular oxygen and water. Typically
these are embedded in a surrounding polymer matrix, such as
poly(lactic-co-glycolic acid) (PLGA),7,8,12 or polydimethyl-
siloxane (PDMS)9 to prolong the oxygen delivery time. These
oxygen producing biomaterials have taken a variety of forms,
including bulk hydrogels,10 a sphere/hydrogel mix,13
scaﬀolds,8 films7 and disks.9 For applications where injection
is necessary, the oxygen producing materials should be
smaller than the internal diameter of the needle. To this end,
various emulsions have been used to create microparticles/
microspheres capable of producing oxygen.14,15
Transplantation to the rodent brain typically requires 30G
needles/cannula with an internal diameter of 160 µm, so we
set out to produce simple and scalable microspheres under
100 µm diameter that were capable of releasing oxygen. It was
hypothesized that modifications of the dual-photoinitiator,
water in oil emulsion-based technique developed by Franco,
C. L., et al.16 could be used to produce high numbers of poly
(ethylene glycol) diacrylate (PEGDA) based oxygen producing
spheres. Furthermore, we aimed to analyze whether these
spheres could rescue three diﬀerent cell types from the
detrimental eﬀects of oxygen and glucose deprivation (harsh
conditions imposed in order to simulate cell transplantation
to the brain).
Spheres consisting of PEGDA and calcium peroxide were
synthesized in the absence of solvent by mixing these two
components with Pluronic F68 (non-ionic surfactant) and
2-hydroxy-2-methylpropiophenone as a photoinitiator (see
Fig. 1 for a schematic depiction of the process). By vortexing
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this mixture within mineral oil (containing Span 85 and Tween
and a second photoinitiator (IRGACURE 651)) an emulsion
was formed which was then exposed to UV light to crosslink
the PEGDA (see ESI† for detailed synthesis procedure). Using
diﬀerent photoinitiators in each phase allows better shaped
microsphere formation as shown previously.16,17 Scanning
electron microscopy (SEM) revealed well-formed, individual
spheres had been produced (Fig. 1c, ESI Fig. S1 and S2†). The
addition of Pluronic F68 to the reaction mixture vastly reduced
the size distribution of the spheres and improved the oxygen
release profile, so was adopted for all subsequent sphere for-
mation (ESI Fig. S2c and S2f†).
As Fig. 1b depicts, to start of the oxygen release process,
contact with water is required. The microsphere production
procedure, in anhydrous conditions, allows dry spheres to be
harvested which retain their potential activity during storage
in dry conditions (see ESI Fig. S3†). Once water has penetrated
the PEG network to contact the CaO2, it is converted to hydro-
gen peroxide. As expected, this reaction intermediate is highly
cytotoxic, which is shown in ESI Fig. S4† via the use of human
SH-SY5Y cells (chosen as a model dopaminergic cell18), which
were cultured in vitro in two conditions; normoxia (21% O2)
and extreme hypoxia (0.1% O2). However, adding catalase to
catalyze the break down process of hydrogen peroxide comple-
tely reverses this loss in cell viability. Analysis of the oxygen
release from the spheres (OXY-4 mini non-invasive oxygen
sensor, PreSens, Germany), showed that an elevated oxygen
concentration lasts up to 16 hours in both normoxic and
hypoxic conditions (see Fig. 1d). Similar release profiles can be
seen for both conditions though a faster rate of oxygen
decrease occurs in hypoxic conditions.
In order to analyze the spheres in cell culture, it was first
desired to analyze the oxygen consumption rate of cells in a
closed system (i.e. no gaseous exchange) with or without the
oxygen producing spheres. Although no transplantation situ-
ation would ever resemble a completely closed system
(however poor the surrounding vasculature is, there would
likely be some minimal amount of oxygen diﬀusion), it would
provide an idea of how quickly the oxygen is consumed from
the transplantation media. Three diﬀerent cell types were
chosen for the following analyses. As mentioned previously,
SH-SY5Y cells are commonly used as a model dopaminergic
cell,18 so these were used as a testing platform herein. Primary
embryonic ventral mesencephalic (VM) cells are commonly
used as a source of dopaminergic neurons for cell transplan-
tation to Parkinsonian animal models19 and to Parkinson’s
disease patients in the TRANSEURO clinical trial.20 In
addition, mesenchymal stem cells (MSCs) produce a poten-
tially neuroprotective secretome,21 so they have also been
investigated for cell transplantation to the Parkinsonian
brain.22,23 To analyse the oxygen consumption rate of these
three cell types, 500 000 cells (a typical number of grafted cells
per brain hemisphere19) were seeded in 350 µL of media into
the well of a 96-well plate equipped with the PreSens non-inva-
sive oxygen probe. A second group of cells were seeded in
media containing the oxygen containing spheres and catalase.
The plate was immediately sealed with a plate sealant and the
dissolved oxygen content measured every minutes. Fig. 2
shows that the highly proliferative SH-SY5Y cells rapidly con-
sumed oxygen, almost depleting all the oxygen in the sealed
chamber by 48 hours. In contrast, the VM cells used compara-
tively little oxygen which stabilized at a level of ∼100 µmol
mL−1 after 24 hours. The MSC consumption was comparable
to that of the SH-SY5Y cells, with a continuing downward
trend being shown up to 48 hours. For all cases, the addition
of oxygen producing spheres created an initial increase in
oxygen level that eventually came down to near that of the cells
seeded in media alone. Since this experiment was designed to
analyse the oxygen consumption rate of a typical graft, it has a
major limitation in that the media volume was far too large.
Fig. 1 Schematic depiction of the PEGDA/CaO2 microsphere synthesis process (a) using the dual photoinitiator (PI) approach. Oxygen production is
shown in (b) whereby contact of the sphere with water produces hydrogen peroxide. The presence of catalase in the surrounding media ensures the
rapid break down of hydrogen peroxide to water and oxygen. Scanning electron microscopy (SEM) image of the oxygen producing spheres (c), and
the corresponding oxygen release proﬁles (d) of diﬀerent concentrations of spheres in normoxic conditions (N) or hypoxic conditions (H).
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Whilst transplantation into rodents typically requires a trans-
plantation volume of up to 4 µL, this experiment used 350 µL,
purely due to limitations of the probe/chamber size. It does,
however, show empirically that diﬀerent cell types have vastly
diﬀerent oxygen consumption rates, and one would expect
complete depletion of oxygen to occur much faster within a
4 µL graft.
Praet et al. have shown that hypoxia in grafts can clearly be
measured as early as six hours post transplantation, and cell
death occurs prior to neoangiogenesis (observed at three days
post transplantation).2 Taken together, there is most likely a
window of opportunity where oxygen producing materials
could improve survival before adequate angiogenesis has
occurred. Depletion of oxygen may, however, be only part of
the detrimental eﬀect to the graft core. Poor diﬀusion of other
nutrients, such as glucose, to the graft core may also be
playing a role in the cell death. To this end, we investigated
the role of both oxygen and glucose simultaneously by cultur-
ing the three cell types in oxygen – glucose deprivation (OGD)
conditions and measuring their metabolic activity (used as a
measure of viability by normalization to control cells) as an
indicator of cell health. Fig. 3 shows that by the second day of
culture, SH-SY5Y cells were slightly eﬀected by hypoxic con-
ditions, which was exacerbated by low glucose. The cell viabi-
lity of VM cells was not aﬀected by extreme hypoxia or low
glucose levels. Remarkably this situation persisted even to five
days of culture time (data not shown). However, MSCs cultured
in low glucose for two, three and four days showed a reduced
cell viability, and hypoxic conditions further reduced this via-
bility after three and four days in culture.
Our studies corroborate the findings of Deschepper et al.,
which shown that MSCs are capable of surviving 21 days in
hypoxic conditions but die if deprived of both oxygen and
glucose simultaneously.24 The authors show that this is due to
a switch to anaerobic metabolism in near anoxic conditions.
Whilst it was clear for SH-SY5Y cells that glucose is playing a
more important role in cell health than oxygen in our experi-
mental set up, there was also a clear diﬀerence in viability
between MSCs cultured in low glucose normoxia and those
cultured in low glucose hypoxia (OGD). Theoretically therefore,
one could envisage that the oxygen producing spheres could
rescue MSCs from the detrimental eﬀects of OGD. Fig. 4 shows
how the addition of oxygen producing spheres to the cell
media of cells cultured in OGD conditions aﬀects cell viability.
As predicted, addition of the oxygen producing spheres has
no eﬀect on VM cell viability since the deprivation of oxygen
does not cause a loss in viability (Fig. 4b). However, on the
second day of culture, SH-SY5Y cells cultured in hypoxia with
0, 0.25 and 0.5 mg mL−1 glucose show a small but significant
improvement in viability in the presence of 1 mg mL−1 oxygen
producing spheres and catalase (Fig. 4a). Larger improvements
in viability can be observed for MSCs cultured in hypoxic con-
ditions with oxygen producing spheres compared to those
without (Fig. 4c). Two other phenomena arise, the first is that
catalase alone (i.e. used without the oxygen producing spheres
but at the same concentration) resulted in increased viability
of the MSCs at many of the diﬀerent glucose concentrations.
The second is that MSCs cultured with catalase and the oxygen
producing spheres together sometimes had higher viability
than the cells cultured in normoxic conditions (normoxia
control on the graphs). The first may be explained by the fact
that MSCs cultured in hypoxic conditions exhibit increased
hydrogen peroxide production which can contribute to cell
death.25 The addition of catalase therefore reduces the level of
hydrogen peroxide and other reactive oxygen species allowing
Fig. 2 Oxygen producing spheres compensate for cellular oxygen con-
sumption. Graphs showing the oxygen consumption of 500 000
SH-SY5Y cells (a), ventral mesencephalic cells (VM) (b) or mesenchymal
stem cells (c) seeded in a sealed chamber either without spheres (grey
line) or with 1 mg mL−1 oxygen producing spheres (blue line) (n = 2,
error bars omitted for clarity).
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better viability. The second phenomena of higher cell viability
in the catalase plus oxygen producing spheres group is harder
to explain, but may be due to a combinatorial eﬀect of
increased oxygen plus the presence of catalase, which could
have resulted in higher glucose metabolic activity rates. It can,
however, be concluded that in these in vitro OGD culture
conditions, the addition of the oxygen producing spheres has
stronger beneficial eﬀects on MSC viability than SH-SY5Y
cells and no eﬀect is seen for VM cells. It should be high-
lighted here that the medium used for the OGD experiments
contained 10% FBS which contained 0.509 mg mL−1 of
glucose. There was therefore an additional final glucose con-
centration of 0.05 mg mL−1 within all glucose concentrations
tested.
Fig. 3 The eﬀect of oxygen-glucose deprivation (OGD) on cell viability. SH-SY5Y cells (a), VM cells (b) and MSCs (c) were cultured in 0.1% oxygen
(hypoxia – dashed lines) or 21% oxygen (normoxia – black lines) in varying concentrations of glucose. Low glucose and low oxygen was detrimental
to the cell health of SH-SY5Y cells and MSCs, n = 4 error bars represent ± standard deviation.
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Praet et al., show that only three days after embryonic fibro-
blasts are grafted to the mouse brain (right capsula externa)
neoangiogenesis within the graft is taking place.2 In this case
the rapid vascularization may be aided by the grafted cells
innate ability to produce VEGF. However, regardless of the cell
type being transplanted to the brain, there will be a window of
delay between grafting and vascularization of the graft. This
window may be in the order of days and weeks (until anasto-
mosed blood vessels formed), but a major limitation of the
oxygen producing materials developed herein is that they
could only provide a source of oxygen for the first 16–20 hours
post transplantation. It is therefore clear, that whilst the data
in Fig. 4 shows sphere mediated rescue occurs in vitro, better
materials need to be prepared that release oxygen over longer
time periods for application in vivo. PEGDA, crosslinked in
anhydrous conditions was chosen as the means to encapsulate
the calcium peroxide and contain the solid breakdown com-
ponents. In this way the spheres could be prepared in the
absence of water and obtained as a dry powder ready for use.
Poly(ethylene glycol) has often been used as a component of
Fig. 4 Oxygen producing spheres improve the viability of SH-SY5Y cells and MSCs cultured in conditions of oxygen-glucose deprivation (OGD).
After two days of OGD culture SH-SY5Y cells show reduced viability compared to those cultured in normoxia which can be reversed by the addition
of catalase and oxygen producing spheres (a). OGD culture has no eﬀect of VM cell culture so no rescue eﬀect was observed through the addition
of oxygen producing spheres (b). MSCs show a loss of viability in OGD conditions which is most pronounced after four days in culture (c). Addition
of catalase and oxygen producing spheres results in a dramatic increase in cell viability. For all studies n = 4, error bars represent ± standard devi-
ation, asterisks represent a statistical signiﬁcant diﬀerence from hypoxia control (two-way ANOVA where *p < 0.05, **p < 0.01., ***p < 0.001).
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biomaterials used in the brain without dramatically elevated
host response,26–29 so was considered a valid starting material.
However, future studies will focus on more hydrophobic poly-
mers to restrict the access of water to the calcium peroxide. A
range of candidate monomers will be used such as the more
hydrophobic ethylene glycol dimethacrylate, di(trimethyl-
olpropane) tetraacrylate and bisphenol A ethoxylate diacrylate
in order to assess whether the oxygen release time can be
increased. In addition, other factors need to be taken into con-
sideration such the method of catalase delivery, and the host
response to the material. In this study catalase was used in
solution (in the media) but future studies may consider
whether it should be tethered to the sphere.14 A clear limit-
ation of this work is the lack in vivo analysis. These studies
have attempted to create an in vitro model that mimics trans-
plantation conditions in order to assess new oxygen producing
biomaterials. Though it may serve good use in initial studies,
extrapolation to the in vivo condition is tenuous and would
need validating with experimental study.
Our data seem to suggest that oxygen producing materials
may improve the survival of grafts of MSCs but not would assist
fetal dopamine cells of the ventral mesencephalon during the
transplantation process. Furthermore, it should be noted that
whilst the presence or absence of oxygen producing spheres
eﬀected SH-SY5Y and MSC viability, the concentration of
glucose in the media appeared to play a much larger role. This
data corroborates the recent findings that glucose is the major
determinant of MSC viability in near anoxic conditions.30
Conclusions
Taken together these experiments present the synthesis of
microscale spheres comprised of calcium peroxide encapsu-
lated in crosslinked poly(ethylene glycol) diacrylate. Once
placed into a solution containing catalase, oxygen is produced
for up to 16 hours. In an attempt to mimic a transplantation
scenario, we show that SH-SY5Y cells and MSCs consume oxygen
more rapidly than VM cells and that they are more sensitive to
culture in OGD conditions. Addition of the oxygen producing
spheres in media containing catalase reverses the detrimental
eﬀect of OGD. This data suggests that co-injecting oxygen produ-
cing materials during cell transplantation may an eﬀective
means to improve cell survival. Future studies should focus on
longer term oxygen release, so as to provide oxygen to the grafted
cells before suﬃcient vascularization of the graft has occurred.
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